Cover%20Photo6_edited_edited_edited.jpg

CUPROUS PHARMACEUTICALS

Providing partners with technologies to create best-in-class nanomedicines

 

INNOVATE & COLLABORATE

THIS IS WHAT WE DO

IMG_4173.jpg
Meeting

NANOTECHNOLOGIES

At Cuprous, we specialize in developing technologies that result in the creation of novel, best-in-class small molecules by overcoming developmental barriers and improving safety and therapeutic activity.

PARTNERSHIPS

Cuprous offers its enabling technologies to its partners to create best-in-class nanomedicines to address unmet medical needs.

 

NEWSROOM

 

DEVELOPMENT AND CHARACTERIZATION OF A NOVEL FLAVOPIRIDOL FORMULATION FOR TREATMENT OF ACUTE MYELOID LEUKEMIA

March 30, 2021

Cuprous' Metaplex Technology has been used to develop a Flavopiridol formulation that provides a 30-fold increase in plasma AUC and an associated increase in therapeutic activity in models of AML.

THE CUPROUS TEAM

Founder, CEO & President

Vice President, Research

Founder, Chief Scientific Officer

Founder, Director of Operations

GHANIA CHIKH, PHD

Scientific Advisor

 

GET IN TOUCH

  • LinkedIn
 

Address

2405 Wesbrook Mall
Vancouver BC V6T 1Z3

Contact

Follow

  • LinkedIn

©2019 by Cuprous Pharmaceuticals.